The Impact of Total Ischemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney Transplantation
Germaine Wong(Children's Hospital at Westmead), Wai H. Lim(The University of Sydney), Armando Teixeira‐Pinto(The University of Sydney), Henry Pleass(Westmead Hospital), Stephen P. McDonald(Royal Adelaide Hospital), Jeremy R. Chapman(University of Miami), Jonathan C. Craig(Flinders University)
Cited by 83
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
|The Lancet|2015|394
A practical guide to multiple imputation of missing data in nephrology
|Kidney International|2020|282